Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Mitogen inactivation of glycogen synthase kinase-3 beta in intact cells via serine 9 phosphorylation.

The Biochemical journal | Nov 1, 1994

http://www.ncbi.nlm.nih.gov/pubmed/7980435

Glycogen synthase kinase-3 (GSK-3), a protein-serine kinase implicated in cell-fate determination and differentiation, phosphorylates several regulatory proteins that are activated by dephosphorylation in response to hormones or growth factors. GSK-3 beta is phosphorylated in vitro at serine 9 by p70 S6 kinase and p90rsk-1, resulting in its inhibition [Sutherland, Leighton, and Cohen (1993) Biochem. J. 296, 15-19]. Using HeLa cells expressing GSK-3 beta or a mutant containing alanine at residue 9, we demonstrate that serine 9 is modified in intact cells and is targeted specifically by p90rsk-1, and that phosphorylation leads to loss of activity. Since p90rsk-1 is directly activated by mitogen-activated protein kinases, agonists of this pathway, such as insulin, repress GSK-3 function.

Pubmed ID: 7980435 RIS Download

Mesh terms: Amino Acid Sequence | Calcium-Calmodulin-Dependent Protein Kinases | Glycogen Synthase Kinase 3 | Glycogen Synthase Kinases | HeLa Cells | Humans | Mitogens | Molecular Sequence Data | Phosphorylation | Point Mutation | Serine

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.